CVS Health Faces Earnings Challenges Ahead of 2027
CVS Health (CVS) has reported a stock return of 19.0% over the past twelve months, surpassing the S&P 500's 12.8% return. During a call on November 4, management raised its full-year 2026 outlook and announced plans to split the company into two entities. The first will retain Aetna, Caremark, and various health services, while the second will focus on CVS Pharmacy, including retail stores and clinics. However, management also indicated potential challenges for one of its business segments in 2027.
The Health Services segment, which encompasses CVS Health's pharmacy services and healthcare delivery, is projected to experience a low point in earnings in 2027. Management expects adjusted operating income for this segment to be at least $7 billion, factoring in anticipated declines in its 340B business and challenges such as a weaker selling season and membership losses among health plan clients.
For Your Trading Desk
Sponsor Spike Success.
This segment is the largest by revenue for CVS Health, generating $190 billion in fiscal 2025, compared to $143 billion for Health Care Benefits, the next largest segment. After a decline in fiscal 2024, revenue for Health Services rose by 9.7% in fiscal 2025, indicating a return to growth. Despite this, investors are cautious, as CVS Health's stock trades at 10.4 times its trailing twelve-month earnings, significantly lower than the S&P 500's 21.9 times.
CVS Health's Growth Outlook and Future Earnings Projections
Management remains optimistic about the future, expecting Health Services to return to growth after 2027, with the 340B business stabilizing by then. The company anticipates adjusted earnings per share of at least $8.65 in 2027, which is about 13% higher than the adjusted baseline for 2026. This forecast suggests a cautious optimism about the company's overall growth trajectory, even as it faces challenges in the near term.
Investors will be closely monitoring the adjusted operating income for Health Services in CVS Health's formal 2027 guidance, which is expected to be provided during the fourth-quarter call in February 2027. The outlook for this segment is critical, as it represents a significant portion of the company's revenue and overall performance.




